Podiatry Associates Pa Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9801 Greenbelt Rd Ste 210, Lanham, MD 20706 Phone: 240-391-6231 |
Natural Motion Foot And Ankle Care Pa Podiatrist - Primary Podiatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 9801 Greenbelt Rd, Suite 210, Lanham, MD 20706 Phone: 240-391-6231 Fax: 240-391-6254 |
Duane Anthony Mckinney, DPM Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 7404 Executive Pl, Suite 501, Lanham, MD 20706 Phone: 301-262-6314 Fax: 301-262-6486 |
Southwest Podiatry, Llc Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 7425 Forbes Blvd, Suite 105, Lanham, MD 20706 Phone: 301-352-7756 Fax: 301-352-7725 |
Mckinney Podiatry Podiatrist - Foot Surgery Medicare: Not Enrolled in Medicare Practice Location: 7404 Executive Pl, Suite 501, Lanham, MD 20706 Phone: 301-262-6314 Fax: 301-262-6486 |
Svetlana Malinsky, Dpm Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 9801 Greenbelt Rd Ste 210, Lanham, MD 20706 Phone: 240-481-3304 Fax: 301-441-9233 |
Dr. Svetlana Malinsky, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9801 Greenbelt Rd Ste 210, Lanham, MD 20706 Phone: 301-288-1346 Fax: 301-441-9233 |
Mitchellville Foot Health, Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7401 Forbes Blvd, Suite B-2, Lanham, MD 20706 Phone: 301-805-9308 |
News Archive
Surgical patients are more likely to experience a postoperative infection if they have low health literacy, which is a limited capacity to understand and act on health information, according to results of a new study presented at the American College of Surgeons 2020 Quality and Safety Conference VIRTUAL.
After the Georgia governor seemed to rule out Medicaid expansion in a convention speech, a spokesman qualified that it might change if the state had options not now on the table.
Light-activated switches are too small to be seen by the naked eye, but the molecular systems are hard at work in research related to drug design, adaptive materials and data storage.
Scientists have routinely used mice to replicate aspects of human breast cancer in an effort to find a cure to the most common type of cancer among women.
Ascletis today announced it received the approval from the Taiwan Food and Drug Administration (TFDA) to start phase II clinical trial for its all-oral interferon (IFN)-free regimen to treat chronic hepatitis C (CHC).
› Verified 6 days ago